Literature DB >> 29467214

Hepatic Transport of 25-Hydroxyvitamin D3 Conjugates: A Mechanism of 25-Hydroxyvitamin D3 Delivery to the Intestinal Tract.

Chunying Gao1, Michael Z Liao1, Lyrialle W Han1, Kenneth E Thummel1, Qingcheng Mao2.   

Abstract

Vitamin D3 is an important prohormone critical for maintaining calcium and phosphate homeostasis in the body and regulating drug-metabolizing enzymes and transporters. 25-Hydroxyvitamin D3 (25OHD3), the most abundant circulating metabolite of vitamin D3, is further transformed to the biologically active metabolite 1α,25-dihydroxyvitamin D3 (1α,25-(OH)2D3) by CYP27B1 in the kidney and extrarenal tissues, and to nonactive metabolites by other cytochrome P450 enzymes. In addition, 25OHD3 undergoes sulfation and glucuronidation in the liver, forming two major conjugative metabolites, 25OHD3-3-O-sulfate (25OHD3-S) and 25OHD3-3-O-glucuronide (25OHD3-G), both of which were detected in human blood and bile. Considering that the conjugates excreted into the bile may be circulated to and reabsorbed from the intestinal lumen, deconjugated to 25OHD3, and then converted to 1α,25-(OH)2D3, exerting local intestinal cellular effects, it is crucial to characterize enterohepatic transport mechanisms of 25OHD3-S and 25OHD3-G, and thereby understand and predict mechanisms of interindividual variability in mineral homeostasis. In the present study, with plasma membrane vesicle and cell-based transport studies, we showed that 25OHD3-G is a substrate of multidrug resistance proteins 2 and 3, OATP1B1, and OATP1B3, and that 25OHD3-S is probably a substrate of breast cancer resistance protein, OATP2B1, and OATP1B3. We also demonstrated sinusoidal and canalicular efflux of both conjugates using sandwich-cultured human hepatocytes. Given substantial expression of these transporters in liver hepatocytes and intestinal enterocytes, this study demonstrates for the first time that transporters could play important roles in the enterohepatic circulation of 25OHD3 conjugates, providing an alternative pathway of 25OHD3 delivery to the intestinal tract, which could be critical for vitamin D receptor-dependent gene regulation in enterocytes.
Copyright © 2018 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29467214      PMCID: PMC5896369          DOI: 10.1124/dmd.117.078881

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  39 in total

1.  Mechanism of polybrominated diphenyl ether uptake into the liver: PBDE congeners are substrates of human hepatic OATP transporters.

Authors:  Erik Pacyniak; Megan Roth; Bruno Hagenbuch; Grace L Guo
Journal:  Toxicol Sci       Date:  2010-02-22       Impact factor: 4.849

Review 2.  Vitamin D deficiency.

Authors:  Michael F Holick
Journal:  N Engl J Med       Date:  2007-07-19       Impact factor: 91.245

3.  ABCG2 transports sulfated conjugates of steroids and xenobiotics.

Authors:  Michiko Suzuki; Hiroshi Suzuki; Yoshikazu Sugimoto; Yuichi Sugiyama
Journal:  J Biol Chem       Date:  2003-04-07       Impact factor: 5.157

4.  Intestinal CYP3A4 and midazolam disposition in vivo associate with VDR polymorphisms and show seasonal variation.

Authors:  Ranjit K Thirumaran; Jatinder K Lamba; Richard B Kim; Brad L Urquhart; Jamie C Gregor; Nilesh Chande; Yiping Fan; An Qi; Cheng Cheng; Kenneth E Thummel; Stephen D Hall; Erin G Schuetz
Journal:  Biochem Pharmacol       Date:  2012-03-30       Impact factor: 5.858

Review 5.  Vitamin K nutrition, metabolism, and requirements: current concepts and future research.

Authors:  Martin J Shearer; Xueyan Fu; Sarah L Booth
Journal:  Adv Nutr       Date:  2012-03-01       Impact factor: 8.701

Review 6.  Vitamin D metabolism, mechanism of action, and clinical applications.

Authors:  Daniel D Bikle
Journal:  Chem Biol       Date:  2014-02-13

Review 7.  Vitamin D: metabolism and biological actions.

Authors:  H L Henry; A W Norman
Journal:  Annu Rev Nutr       Date:  1984       Impact factor: 11.848

8.  Extra-renal 25-hydroxyvitamin D3-1alpha-hydroxylase in human health and disease.

Authors:  Martin Hewison; Fiona Burke; Katie N Evans; David A Lammas; David M Sansom; Philip Liu; Robert L Modlin; John S Adams
Journal:  J Steroid Biochem Mol Biol       Date:  2007-03       Impact factor: 4.292

9.  Effects of vitamin D supplementation in atorvastatin-treated patients: a new drug interaction with an unexpected consequence.

Authors:  J B Schwartz
Journal:  Clin Pharmacol Ther       Date:  2008-08-27       Impact factor: 6.875

10.  MK571 inhibits phase-2 conjugation of flavonols by Caco-2/TC7 cells, but does not specifically inhibit their apical efflux.

Authors:  Robert D Barrington; Paul W Needs; Gary Williamson; Paul A Kroon
Journal:  Biochem Pharmacol       Date:  2015-03-20       Impact factor: 5.858

View more
  5 in total

1.  Drug Transporters in Xenobiotic Disposition and Pharmacokinetic Prediction.

Authors:  Qingcheng Mao; Yurong Lai; Joanne Wang
Journal:  Drug Metab Dispos       Date:  2018-05       Impact factor: 3.922

Review 2.  Recent advances in the ontogeny of drug disposition.

Authors:  Brian D Chapron; Alenka Chapron; J Steven Leeder
Journal:  Br J Clin Pharmacol       Date:  2021-04-15       Impact factor: 3.716

3.  Role of glucuronidated 25-hydroxyvitamin D on colon gene expression in mice.

Authors:  Carmen J Reynolds; Nicholas J Koszewski; Ronald L Horst; Donald C Beitz; Jesse P Goff
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2020-07-06       Impact factor: 4.871

4.  Modulation of Plasma 25-Hydroxyvitamin D3 Level by Imatinib Mesylate in Patients with Chronic Myelogenous Leukemia: The Role of Uptake and Efflux Transporters.

Authors:  Mervat M Omran; Samia A Shouman; Raafat Abdelfattah; Heba S Moussa; Nadia A Thabet; Marwa S Hamza
Journal:  Curr Ther Res Clin Exp       Date:  2022-09-01

Review 5.  Psoriasis: From Pathogenesis to Pharmacological and Nano-Technological-Based Therapeutics.

Authors:  Robert Gironés Petit; Amanda Cano; Alba Ortiz; Marta Espina; Josefina Prat; Montserrat Muñoz; Patrícia Severino; Eliana B Souto; Maria L García; Montserrat Pujol; Elena Sánchez-López
Journal:  Int J Mol Sci       Date:  2021-05-07       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.